GLYCANOVA AS
994035495ActiveNorwegian biotech developing superior mushroom beta-glucans for human and animal health.
Biotechnology Companyglycanova.com
Yleiskatsaus
- Tuntematon
- Työntekijät
- 1.4milj NOK
- Liikevaihto
- 2009
- Perustettu
Avainpäättäjät
Dr. Ajay K. Agrawal
Advisory Board Member
Anne Torill Hovland
Head of Process Development
Lewis Linden
Chief Operating Officer
Dr. Ron Amen
Executive Vice President (Sales and Marketing USA)
+1 lisää yhteystietoja Funnelfeedrissä
Kuvaus
GlycaNova is an innovative, privately owned Norwegian biotechnology company specializing in immune system modulation. Its core focus is leveraging proprietary 1,3 beta-glucans extracted from medicinal mushrooms. The company utilizes a unique manufacturing process that preserves the triple helix stru...
Biogaia New Sciences AB